NEUROLOGISTS REPORTED THAT MSers WERE MOST SATISFIED WITH AND ADHERENT TO GILENYA
STUDY:
BACKGROUND:
Multiple
sclerosis (MS) is a complex disease with many therapeutic options.
Little is known about how neurologists select particular
disease-modifying therapies (DMTs) for their patients.
Post a Comment